Inflectra to be PBS listed from December

inflectra story, checkered race winning flag

Pfizer today confirmed that the first mAb biosimilar, Inflectra (infliximab), will be added to the PBS on 1 December 2015 for the treatment of eight inflammatory conditions.

This content is restricted. If you have already registered on the AJP website please login below, Or you can Register for free.

Register here

Forgot Password?Why do I need to login & stay in?

Previous Guild moving on harm minimisation: Tambassis
Next FIP releases resources for helping refugees

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.

No Comment

Leave a reply